156 related articles for article (PubMed ID: 33494688)
1. Exploring the Mitochondrial Apoptotic Cell Death Landscape and Associated Components Serving as Molecular Targets, Primarily for Synthetic and Natural Drugs Targeting Oncology Therapeutics.
Kaur I; Behl T; Sachdeva M; Bungau S; Venkatachalam T
Curr Mol Pharmacol; 2021; 14(6):1066-1082. PubMed ID: 33494688
[TBL] [Abstract][Full Text] [Related]
2. Cancer and Apoptosis.
Chaudhry GE; Akim AM; Sung YY; Muhammad TST
Methods Mol Biol; 2022; 2543():191-210. PubMed ID: 36087269
[TBL] [Abstract][Full Text] [Related]
3. Smac/DIABLO and colon cancer.
Anguiano-Hernandez YM; Chartier A; Huerta S
Anticancer Agents Med Chem; 2007 Jul; 7(4):467-73. PubMed ID: 17630921
[TBL] [Abstract][Full Text] [Related]
4. Bax/Bak-dependent, Drp1-independent Targeting of X-linked Inhibitor of Apoptosis Protein (XIAP) into Inner Mitochondrial Compartments Counteracts Smac/DIABLO-dependent Effector Caspase Activation.
Hamacher-Brady A; Brady NR
J Biol Chem; 2015 Sep; 290(36):22005-18. PubMed ID: 26134559
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2.
Adrain C; Creagh EM; Martin SJ
EMBO J; 2001 Dec; 20(23):6627-36. PubMed ID: 11726499
[TBL] [Abstract][Full Text] [Related]
6. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis.
Guo F; Nimmanapalli R; Paranawithana S; Wittman S; Griffin D; Bali P; O'Bryan E; Fumero C; Wang HG; Bhalla K
Blood; 2002 May; 99(9):3419-26. PubMed ID: 11964312
[TBL] [Abstract][Full Text] [Related]
7. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway.
Srinivasula SM; Datta P; Fan XJ; Fernandes-Alnemri T; Huang Z; Alnemri ES
J Biol Chem; 2000 Nov; 275(46):36152-7. PubMed ID: 10950947
[TBL] [Abstract][Full Text] [Related]
8. Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria.
Yamaguchi H; Bhalla K; Wang HG
Cancer Res; 2003 Apr; 63(7):1483-9. PubMed ID: 12670894
[TBL] [Abstract][Full Text] [Related]
9. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway.
Yang X; Fraser M; Moll UM; Basak A; Tsang BK
Cancer Res; 2006 Mar; 66(6):3126-36. PubMed ID: 16540663
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways.
Suzuki Y; Takahashi-Niki K; Akagi T; Hashikawa T; Takahashi R
Cell Death Differ; 2004 Feb; 11(2):208-16. PubMed ID: 14605674
[TBL] [Abstract][Full Text] [Related]
11. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis.
Han J; Goldstein LA; Gastman BR; Rabinowich H
J Biol Chem; 2006 Apr; 281(15):10153-63. PubMed ID: 16478725
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells.
Pardo OE; Lesay A; Arcaro A; Lopes R; Ng BL; Warne PH; McNeish IA; Tetley TD; Lemoine NR; Mehmet H; Seckl MJ; Downward J
Mol Cell Biol; 2003 Nov; 23(21):7600-10. PubMed ID: 14560006
[TBL] [Abstract][Full Text] [Related]
13. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction.
Hegde R; Srinivasula SM; Zhang Z; Wassell R; Mukattash R; Cilenti L; DuBois G; Lazebnik Y; Zervos AS; Fernandes-Alnemri T; Alnemri ES
J Biol Chem; 2002 Jan; 277(1):432-8. PubMed ID: 11606597
[TBL] [Abstract][Full Text] [Related]
14. Optimization and validation of mitochondria-based functional assay as a useful tool to identify BH3-like molecules selectively targeting anti-apoptotic Bcl-2 proteins.
Long J; Liu L; Nikolovska-Coleska Z; Shangary S; Yi H; Wang S; Wang S
BMC Biotechnol; 2013 May; 13():45. PubMed ID: 23705845
[TBL] [Abstract][Full Text] [Related]
15. Endogenously released Smac is insufficient to mediate cell death of human lung carcinoma in response to etoposide.
Bartling B; Lewensohn R; Zhivotovsky B
Exp Cell Res; 2004 Aug; 298(1):83-95. PubMed ID: 15242764
[TBL] [Abstract][Full Text] [Related]
16. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria.
Zhang XD; Borrow JM; Zhang XY; Nguyen T; Hersey P
Oncogene; 2003 May; 22(19):2869-81. PubMed ID: 12771938
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis regulators.
Harada H; Grant S
Rev Clin Exp Hematol; 2003 Jun; 7(2):117-38. PubMed ID: 14763159
[TBL] [Abstract][Full Text] [Related]
18. Cephalostatin 1 selectively triggers the release of Smac/DIABLO and subsequent apoptosis that is characterized by an increased density of the mitochondrial matrix.
Dirsch VM; Müller IM; Eichhorst ST; Pettit GR; Kamano Y; Inoue M; Xu JP; Ichihara Y; Wanner G; Vollmar AM
Cancer Res; 2003 Dec; 63(24):8869-76. PubMed ID: 14695204
[TBL] [Abstract][Full Text] [Related]
19. Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells.
Pruefer FG; Lizarraga F; Maldonado V; Melendez-Zajgla J
J Chemother; 2008 Jun; 20(3):348-54. PubMed ID: 18606591
[TBL] [Abstract][Full Text] [Related]
20. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO).
Ng CP; Bonavida B
Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
